1. Home
  2. JAGX vs PTPI Comparison

JAGX vs PTPI Comparison

Compare JAGX & PTPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • PTPI
  • Stock Information
  • Founded
  • JAGX 2013
  • PTPI 2020
  • Country
  • JAGX United States
  • PTPI United States
  • Employees
  • JAGX N/A
  • PTPI N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • PTPI Biotechnology: Pharmaceutical Preparations
  • Sector
  • JAGX Health Care
  • PTPI Health Care
  • Exchange
  • JAGX Nasdaq
  • PTPI Nasdaq
  • Market Cap
  • JAGX 3.1M
  • PTPI 2.6M
  • IPO Year
  • JAGX N/A
  • PTPI N/A
  • Fundamental
  • Price
  • JAGX $4.46
  • PTPI $0.07
  • Analyst Decision
  • JAGX
  • PTPI
  • Analyst Count
  • JAGX 0
  • PTPI 0
  • Target Price
  • JAGX N/A
  • PTPI N/A
  • AVG Volume (30 Days)
  • JAGX 40.9K
  • PTPI 95.8M
  • Earning Date
  • JAGX 03-31-2025
  • PTPI 05-14-2025
  • Dividend Yield
  • JAGX N/A
  • PTPI N/A
  • EPS Growth
  • JAGX N/A
  • PTPI N/A
  • EPS
  • JAGX N/A
  • PTPI N/A
  • Revenue
  • JAGX $11,689,000.00
  • PTPI $5,112,043.00
  • Revenue This Year
  • JAGX $18.18
  • PTPI N/A
  • Revenue Next Year
  • JAGX $40.06
  • PTPI $0.76
  • P/E Ratio
  • JAGX N/A
  • PTPI N/A
  • Revenue Growth
  • JAGX 19.75
  • PTPI N/A
  • 52 Week Low
  • JAGX $4.40
  • PTPI $0.05
  • 52 Week High
  • JAGX $540.00
  • PTPI $1.00
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 20.11
  • PTPI 40.68
  • Support Level
  • JAGX $4.41
  • PTPI $0.06
  • Resistance Level
  • JAGX $4.97
  • PTPI $0.11
  • Average True Range (ATR)
  • JAGX 0.74
  • PTPI 0.02
  • MACD
  • JAGX 0.22
  • PTPI 0.00
  • Stochastic Oscillator
  • JAGX 3.95
  • PTPI 8.12

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About PTPI Petros Pharmaceuticals Inc.

Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.

Share on Social Networks: